Primary Immune Deficiency (PID) Therapeutics Pipeline Review, H1 2019 Edition – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Primary Immune Deficiency (PID) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Primary…